Vincerx Pharma Inc.
0.15
-0.02 (-12.13%)
At close: Jan 15, 2025, 3:59 PM
0.15
-0.13%
After-hours Jan 15, 2025, 07:55 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue 915.00K 939.00K 340.00K 173.00K 173.00K
Gross Profit -915.00K -939.00K -340.00K -173.00K -173.00K
Operating Income -42.61M -73.57M -62.66M -10.71M -45.00K
Interest Income 1.25M 664.00K n/a 54.27K 54.27K
Pretax Income -40.16M -65.37M -39.31M -10.72M -45.00K
Net Income -40.16M -57.16M -15.61M -10.73M -45.00K
Selling & General & Admin 13.64M 18.95M 22.57M 3.60M 45.00K
Research & Development 28.06M 52.15M 40.08M 7.12M n/a
Other Expenses n/a 1.24M -8.00K -8.00K n/a
Operating Expenses 42.61M 71.11M 62.66M 10.71M 45.00K
Interest Expense n/a n/a n/a 8.00K n/a
Selling & Marketing Expenses n/a n/a n/a n/a 44.95K
Cost & Expenses 42.61M 71.11M 62.66M 10.71M 45.00K
Income Tax n/a -8.21M -23.70M 8.00K -54
Shares Outstanding (Basic) 21.30M 21.03M 17.18M 13.98M 5.20M
Shares Outstanding (Diluted) 21.30M 21.03M 17.18M 13.98M 5.20M
EPS (Basic) -1.89 -2.72 -0.91 -0.77 -0.01
EPS (Diluted) -1.89 -2.72 -0.91 -0.77 -0.01
EBITDA -42.61M -68.67M -62.66M -10.71M 9.00K
Depreciation & Amortization 52.00K 939.00K 340.00K 5.71M 54.00K